Anticoagulation and antiplatelet therapy in acute coronary syndromes.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24493493.
- Also identified by DOI 10.3949/ccjm.81a.13016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antiplatelet and anticoagulant drugs are the mainstay of treatment of acute coronary syndrome (ACS). The last 30 years have seen the development of various agents, a deeper understanding of the pathobiology of this disease, and an evolution in its treatment. We review the role of contemporary agents in ACS and highlight key clinical trials of these agents.
Medical subject headings
- Acute Coronary Syndrome
- Anticoagulants
- Platelet Aggregation Inhibitors